CARsgen's Series B Round

CARsgen raised a round of funding on January 25, 2016.

CARsgen (科济生物) is an immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has r…

Articles about CARsgen's Series B Round: